Legitimacy in the absence of double-blind randomised clinical trials
A double-blind randomised clinical trial prevents bias when evaluating patient outcomes, validating the research. It is referred to as a double-blind study, as neither the researcher nor the patient knows who has received an intervention and who has received a placebo.
However, it is almost impossible to conduct double-blind studies in psychotherapy, and consequently psychedelic-assisted therapy, due to the patient’s active involvement in the therapy component.
The client will only access psilocybin at a licensed service centre during an administration session in the presence of a licensed facilitator. An optional integration session will be offered to a client after the administration session.
READ MORE
